# A Study to Evaluate the Absorption, Metabolism, and Excretion (ADME) of BMS-986435

> **NCT05686096** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 7 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** MYK-224

## Key facts

- **NCT ID:** NCT05686096
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-16
- **Primary completion:** 2023-04-08
- **Final completion:** 2023-04-08
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2023-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05686096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05686096, "A Study to Evaluate the Absorption, Metabolism, and Excretion (ADME) of BMS-986435". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05686096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*